Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 59 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
O+MEDICALE from Sint-Gillis (bij-Brussel), company number BE0890342907, closed financial year 2025 with a result of € 15,864 after tax. For that financial year O+MEDICALE recorded a gross margin of € 137,941 and equity of € 92,478. Compared with financial year 2024, the result moved from € 17,151 to € 15,864. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.
€ 92,478
▲ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,864
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 57,640
▲ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 73,878.
People and assets in 2025
0.6
Average over the fiscal year, from the social balance sheet.
€ 23,246
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 134,391
▼ 39% vs 2024
€ 96,673 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.
€ 483
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,687
▼ 43% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 120,850 | € 130,860 | € 137,693 | € 137,941 | |
| Profit after taxes | € -51,107 | € 1,139 | € 17,151 | € 15,864 | ▼ 8% |
| Equity | € 57,832 | € 59,463 | € 76,614 | € 92,478 | ▲ 21% |
| Total debts | € 442,510 | € 373,896 | € 279,237 | € 203,875 | ▼ 27% |
| Cash | € 29,908 | € 17,612 | € 52,376 | € 57,640 | ▲ 10% |
| Land & buildings | € 395,483 | € 304,841 | € 219,632 | € 129,193 | ▼ 41% |
| Retained profit | € 39,232 | € 40,863 | € 58,014 | € 73,878 | ▲ 27% |
| Bank debt | € 365,935 | € 307,697 | € 221,872 | € 134,391 | ▼ 39% |
| Balance sheet total | € 500,342 | € 433,359 | € 355,851 | € 296,353 | ▼ 17% |
| Employees (FTE) | 0.7 | 0.7 | 0.6 | 0.6 |
Key figures of O+MEDICALE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to O+MEDICALE?
What happened at O+MEDICALE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 15,864 (▼ 8% vs 2024). filed late Source: NBB ↗
- New establishment in Sint-Gillis (bij-Brussel). KBO
- Start of the company according to the CBE. KBO
- Rudy GEVERS became a director. NBB
- Jean MAKHOUL became a director. NBB
In short
From € 51,107 loss in 2022 to € 15,864 profit in 2025.
Best year ever: 2024, with € 17,151 profit.
A new publication or filing at O+MEDICALE? We notify you, reason included.
Follow O+MEDICALEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind O+MEDICALE are Rudy GEVERS, Jean MAKHOUL and Jamil SOTO. Rudy GEVERS is also behind GYNSEN. Jamil SOTO is also behind DOCTEUR SOTO GYNECOLOGIE.
Directors
According to the 2025 annual accounts
since 2007
Jean MAKHOUL
Manager
since 2007
Establishments
Establishment units
Physical locations of this company
Henri Jasparlaan 113
1060 Sint-Gillis (bij-Brussel)
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →Chambre de Commerce italienne en Belgique-Chambre de Commercde Belgo-Italienne - Chambre de Commerce Italo-Belge - Italiaanse Kamer Van Koophandel in Belgïe - Belgisch-Italiaanse Kaer van Koop
Maison ENGLEBERT société anonyme
VERS.A architectenvennootschap – VERS.A Société d’architectes
€ 129,819 gross margin · 2025
DWMS
€ -8,868 gross margin · 2025
MAGALIE DEBERGH
€ 91,627 gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0890.342.907
- VAT number
- BE 0890.342.907
- Registered office
- Henri Jasparlaan 113, 1060 Sint-Gillis (bij-Brussel)
- Names & denominations
- O+MEDICALE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 June 2007
- Peppol
- Active · Active since 26 Dec 2025
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen